Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026


RESEARCH TRIANGLE PARK, N.C., May 07, 2026 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2026 financial results before the opening of the U.S. financial markets on Thursday, May 14, 2026. Management will host a conference call and webcast that day to discuss the Company’s financial and business results.



Source link

  • Related Posts

    The philosophy behind the pro-steroid Enhanced Games

    The Enhanced Group’s (ENHA) controversial Enhanced Games will debut in Las Vegas this Memorial Day Weekend. The competition features athletes who are taking performance-enhancing drugs while being medically supervised for…

    Saudis feared Trump’s Project Freedom would spur Iran to attack, officials say

    Saudi officials were angered by President Donald Trump’s surprise announcement that the U.S. would start guiding ships through the Strait of Hormuz, fearing the move could spur more Iranian attacks…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Russia Has Lost More Than 350,000 Soldiers, New Estimate Finds

    Russia Has Lost More Than 350,000 Soldiers, New Estimate Finds

    Why Canada needs to start taking Alberta’s separatist movement seriously

    The Mini Bag Trend That It Girls Are Swapping XL Totes For

    The Mini Bag Trend That It Girls Are Swapping XL Totes For

    Part I, Volume 158, 2nd quarterly index

    The philosophy behind the pro-steroid Enhanced Games

    The philosophy behind the pro-steroid Enhanced Games

    DNA identifies four more crew members of doomed Franklin expedition

    DNA identifies four more crew members of doomed Franklin expedition